Literature DB >> 28587437

Overexpression and correlation of HIF-2α, VEGFA and EphA2 in residual hepatocellular carcinoma following high-intensity focused ultrasound treatment: Implications for tumor recurrence and progression.

Lun Wu1, You-Shun Zhang1, Meng-Liang Ye2, Feng Shen1, Wei Liu3, Hong-Sheng Hu1, Sheng-Wei Li4, Hong-Wei Wu1, Qin-Hua Chen1, Wen-Bo Zhou1.   

Abstract

Rapid growth of residual tumors can occur as a result of their recurrence and progression. The present study aimed to investigate the expression of hypoxia inducible factor-2 subunit α (HIF-2α), vascular endothelial growth factor A (VEGFA), erythropoietin-producing hepatocellular A2 (EphA2) and angiogenesis in residual hepatocellular carcinoma (HCC), following treatment with high-intensity focused ultrasound (HIFU) ablation, in order to investigate the association between protein expression and tumor recurrence and growth. Athymic BALB/c (nu/nu) mice were subcutaneously inoculated with the HCC cell line HepG2, in order to create xenograft tumors. Approximately 30 days post-inoculation, eight mice were treated with HIFU, whereas eight mice received no treatment and acted as the control group. Residual tumor tissues were obtained from the experimental groups after one month. Levels of HIF-2α, VEGFA, EphA2 and cluster of differentiation 31 (CD31) expression was measured by immunohistochemical staining. CD31-positive vascular endothelial cells were counted to calculate microvascular density (MVD), and western blot analysis was performed to determine levels of HIF-2α, VEGFA, and EphA2 protein. It was found that the expression levels of HIF-2α, VEGFA, EphA2, and MVD proteins in residual HCC tissues were significantly higher than in the control group tissues (P<0.05). Tumor MVD was strongly correlated with VEGFA (R=0.957, P<0.01) and EphA2 (R=0.993, P<0.01) protein expression levels. Furthermore, there was a significant positive correlation between HIF-2α and EphA2 expression (R=0.991, P<0.01). The correlation between VEGFA and EphA2 expression was also positive (R=0.985, P<0.01). These data suggest that overexpression of HIF-2α, VEGFA and EphA2 is related to angiogenesis in residual HCC following HIFU ablation, potentially via their association with key mediators of recurrence.

Entities:  

Keywords:  angiogenesis; erythropoietin-producing hepatocellular A2; hypoxia inducible factor-2 subunit α; residual hepatocellular carcinoma; vascular endothelial growth factor A

Year:  2017        PMID: 28587437      PMCID: PMC5450759          DOI: 10.3892/etm.2017.4428

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  42 in total

1.  Downregulating hypoxia-inducible factor-2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma.

Authors:  Changjun He; Xue-Pu Sun; Haiquan Qiao; Xian Jiang; Dongdong Wang; Xiangguo Jin; Xuesong Dong; Jizhou Wang; Hongchi Jiang; Xueying Sun
Journal:  Cancer Sci       Date:  2012-01-13       Impact factor: 6.716

2.  VEGF increases paracellular permeability in brain endothelial cells via upregulation of EphA2.

Authors:  Ziwei Miao; Yanbin Dong; Wengang Fang; Deshu Shang; Dongxin Liu; Ke Zhang; Bo Li; Yu-Hua Chen
Journal:  Anat Rec (Hoboken)       Date:  2014-01-24       Impact factor: 2.064

3.  Follow-up of high-intensity focused ultrasound treatment for patients with hepatocellular carcinoma.

Authors:  Guoliang Xu; Guangyu Luo; Longjun He; Jianjun Li; Hongbo Shan; Rong Zhang; Yin Li; Xiaoyan Gao; Shiyong Lin; Guobao Wang
Journal:  Ultrasound Med Biol       Date:  2011-10-27       Impact factor: 2.998

4.  MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway.

Authors:  Xin Yang; Xiao-Fei Zhang; Xu Lu; Hu-Liang Jia; Lei Liang; Qiong-Zhu Dong; Qing-Hai Ye; Lun-Xiu Qin
Journal:  Hepatology       Date:  2014-04-01       Impact factor: 17.425

Review 5.  Eph receptors and ephrins: therapeutic opportunities.

Authors:  Antonio Barquilla; Elena B Pasquale
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-03       Impact factor: 13.820

6.  AMPK activation reduces vascular permeability and airway inflammation by regulating HIF/VEGFA pathway in a murine model of toluene diisocyanate-induced asthma.

Authors:  Seoung Ju Park; Kyung Sun Lee; So Ri Kim; Han Jung Chae; Wan Hee Yoo; Dong Im Kim; Myoung Shin Jeon; Yong Chul Lee
Journal:  Inflamm Res       Date:  2012-06-13       Impact factor: 4.575

7.  EFNA1 ligand and its receptor EphA2: potential biomarkers for hepatocellular carcinoma.

Authors:  Xiang-Dan Cui; Mi-Jin Lee; Goung-Ran Yu; In-Hee Kim; Hee-Chul Yu; Eun-Young Song; Dae-Ghon Kim
Journal:  Int J Cancer       Date:  2010-02-15       Impact factor: 7.396

Review 8.  Stereotactic body radiation therapy: A novel treatment modality for inoperable hepatocellular carcinoma.

Authors:  Maobin Meng; Huanhuan Wang; Xianliang Zeng; Lujun Zhao; Zhiyong Yuan; Ping Wang; Xishan Hao
Journal:  Drug Discov Ther       Date:  2015-10

9.  Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1α/VEGFA.

Authors:  Jian Kong; Jinge Kong; Bing Pan; Shan Ke; Shuying Dong; Xiuli Li; Aimin Zhou; Lemin Zheng; Wen-bing Sun
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

Review 10.  Hypoxia-inducible factors as molecular targets for liver diseases.

Authors:  Cynthia Ju; Sean P Colgan; Holger K Eltzschig
Journal:  J Mol Med (Berl)       Date:  2016-04-20       Impact factor: 4.599

View more
  3 in total

1.  Cancer-associated fibroblasts promote gastric tumorigenesis through EphA2 activation in a ligand-independent manner.

Authors:  Hea Nam Hong; You Jin Won; Ju Hee Shim; Hyun Ji Kim; Seung Hee Han; Byung Sik Kim; Hee Sung Kim
Journal:  J Cancer Res Clin Oncol       Date:  2018-06-12       Impact factor: 4.553

2.  Expression and role of VEGFA and miR-381 in portal vein tumor thrombi in patients with hepatocellular carcinoma.

Authors:  Jing Wang; Shuzhi Wu; Tianren Huang
Journal:  Exp Ther Med       Date:  2018-05-03       Impact factor: 2.447

3.  Pre-Exposure to Stress-Inducing Agents Increase the Anticancer Efficacy of Focused Ultrasound against Aggressive Prostate Cancer Cells.

Authors:  Hakm Y Murad; Partha K Chandra; Charles A Kelly; Namrata Khurana; Heng Yu; Emma P Bortz; Shirley N Hong; Debasis Mondal; Damir B Khismatullin
Journal:  Antioxidants (Basel)       Date:  2022-02-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.